Brain inflammation is believed to impair nerve function and increase BBB permeability during major depressive disorder
Professional supervision ensures correct storage, dosing accuracy, and response monitoring, reducing preventable complications
SDP has received research funding from AstraZeneca, Boehringer Ingelheim, Novartis Pharmaceuticals Co., and Merck Sharpe & Dohme, and is a consultant for or has received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Laboratoires Servier, Merck Sharp & Dohme, Novartis Pharmaceuticals Co., Novo Nordisk, Sanofi, and Takeda
glucose tolerance test (IPGTT) or plasma glucose during ad libitum (AL) feeding (Extended Data Fig